NCT06540378View on ClinicalTrials.gov

Stiripentol for the Treatment of Refractory Status Epilepticus

CompletedOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2023

Study Completion Date

May 31, 2024

Conditions

Status Epilepticus

Interventions

DRUG

Stiripentol

All Listed Sponsors

lead

University Hospital Marburg

OTHER

NCT06540378 - Stiripentol for the Treatment of Refractory Status Epilepticus | Biotech Hunter | Biotech Hunter